VITAE PHARMACEUTICALS INC

Inactief instrument

Koers Vitae Pharmaceuticals Inc

Aandelen

US92847N1037

Farmaceutische producten

slotkoers Nasdaq Andere beurzen
- ^USD	-

op al onze abonnementen*

Profiteer van dit aanbod

*Zie voorwaarden op de site

Nieuws in andere talen over Vitae Pharmaceuticals Inc

Vitae Pharmaceuticals : Allergan and Vitae Pharmaceuticals Announce Expiration of HSR Waiting Period for Allergan's Proposed Acquisition of Vitae	17-10-16
Brower Piven Commences An Investigation Into The Proposed Sale Of Vitae Pharmaceuticals, Inc. And Encourages Shareholders To Contact The Firm For Additional Information	15-09-16
Brower Piven Commences An Investigation Into The Proposed Sale Of Vitae Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information	15-09-16
NASDAQ Comp : Wall Street termine dans le rouge, Apple monte encore	14-09-16
Vitae Pharmaceuticals : Allergan to Acquire Vitae Pharmaceuticals Adding Innovative Development Programs for Dermatologic Conditions	14-09-16

Managers en directeuren - Vitae Pharmaceuticals Inc

Managers	Titel	Leeftijd	Van
Ambrose Bailey PSD	President	60	25-10-16
Carole A. Sable CTO	Chief Tech/Sci/R&D Officer	62	06-06-16
John Grosso BRD	Director/Board Member	-	-

Besturend	Titel	Leeftijd	Van
John Grosso BRD	Director/Board Member	-	-

Bedrijfsprofiel

Sector

Farmaceutische producten

Meer informatie over het bedrijf

Sector Biofarmaceutica

	Vaira. 1 jan.	Kapi.
CSL LIMITED	-3,05%	90,45 mld.
SAMSUNG BIOLOGICS CO.,LTD.	+3,95%	41,45 mld.
BIOGEN INC.	-10,51%	33,57 mld.
UCB	+60,58%	25,73 mld.
BIOMARIN PHARMACEUTICAL INC.	-20,09%	14,73 mld.
INCYTE CORPORATION	-8,92%	12,82 mld.
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-11,46%	11,7 mld.
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43,05%	11,44 mld.
SWEDISH ORPHAN BIOVITRUM AB	+5,17%	8,79 mld.

Biofarmaceutica

-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.

PROFITEER NU